TrialEuropean heart journal2018

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.

Michiel Rienstra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.